Prostate Cancer

Aims & Scope

Prostate Cancer is a peer-reviewed, Open Access journal that provides a multidisciplinary platform for scientists, surgeons, oncologists and clinicians working on prostate cancer.

The journal publishes original research articles, review articles, and clinical studies related to the diagnosis, surgery, radiotherapy, drug discovery and medical management of the disease.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 950.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent

  Citation: 170

  Authors: Timothy R., Susan S., Bao-Li, Clareann H., Iona, Kathleen, Rosalind, Pedro, Veda N., Serigne M., Christopher A., Brian E., Chris F., Jennifer J., Sue Ann, William, Mohamed, Esther M., Adam S., LaCreis R., Penelope, Robin J., Christine, Michael N., Elaine A., Jong Y., Alan L., Catherine M., Camille, Robin A., Benjamin A., Janet L., Sara, Ian M., John, Jianfeng, Edward, Ann W., Charnita M.

• The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton

  Citation: 93

  Authors: Emma, Davina A. F., Gerald M. Y.

• Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment

  Citation: 81

  Authors: Teresa Maria Santos, Daniela, Isabel, Luis

• Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001–2007

  Citation: 64

  Authors: Jun, Joseph A., Ashwini, Sun Hee, Viraj A.

• Mouse Models of Prostate Cancer

  Citation: 61

  Authors: Kenneth C., Bart O.

• Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy

  Citation: 59

  Authors: Mankgopo M., Asgar A., Muhammed M., Mike, Razia

• Prostate Cancer Incidence Rates in Africa

  Citation: 56

  Authors: Lisa W., Jamie, Susan S., Sabah M., Hongmei, Ann W.

• Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients

  Citation: 54

  Authors: Ulka, Archana, Ritesh, Nicola, Lawrence G.

• Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology

  Citation: 51

  Authors: Brian W. C., Kieran F., Pamela J.

• <i>CHEK2</i><b>^∗</b>1100delC Mutation and Risk of Prostate Cancer

  Citation: 47

  Authors: Victoria, Maren, Jong Y.